Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tobira Therapeutics Inc (NASDAQ:TBRA)

13.62
Delayed Data
As of Aug 28
 +0.34 / +2.56%
Today’s Change
7.20
Today|||52-Week Range
24.31
+65.74%
Year-to-Date
No recent news for Tobira Therapeutics Inc.

Today’s Trading

Previous close13.28
Today’s open13.15
Day’s range13.15 - 13.74
Volume27,951
Average volume (3 months)76,410
Market cap$231.6M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+44.66%
Earnings growth (this year)+33.86%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.43

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...0.000.00%
CORICorium International...-0.27-2.52%
NVLSNivalis Therapeutics...-0.24-1.55%
ASMBAssembly Biosciences...+0.36+2.78%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$2.16
Annual revenue (last year)$0.00
Annual profit (last year)-$63.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Laurent Fischer
Chief Operating Officer
Helen Jenkins
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers